Chemical Structure : Paquinimod
CAS No.: 248282-01-1
货号: PC-23824Not For Human Use, Lab Use Only.
Paquinimod (ABR-215757) is a specific inhibitor of S100A9, inhibits S100A8/S100A9 binding to RAGE, reduces diabetes-induced thrombocytosis.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥780 | In stock | |
10 mg | ¥1180 | In stock | |
25 mg | ¥2180 | In stock | |
50 mg | ¥3580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Paquinimod (ABR-215757) is a specific inhibitor of S100A9, inhibits S100A8/S100A9 binding to RAGE, reduces diabetes-induced thrombocytosis.
Paquinimod (ABR-215757) significantly reduces the accumulation of Ly6C(hi) inflammatory monocytes and eosinophils, but not neutrophils in necrotic cells.
Paquinimod (ABR-215757) inhibits the Zn++-Dependent Interaction between S100A9 and RAGE & TLR4.
Paquinimod (ABR-215757) inhibits acute experimental autoimmune encephalomyelitis in mice, also inhibits TNFalpha release in a S100A9-dependent model in vivo.
分子量 | 350.42 | |
分子式 | C21H22N2O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N,5-Diethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide |
1. Björk P, et al. PLoS Biol. 2009;7(4):e97.
2. Stenström M, et al. Int Immunopharmacol. 2010 Aug;10(8):837-42.
3. Kraakman MJ, et al. J Clin Invest. 2017 Jun 1;127(6):2133-2147.
4. Tahvili S, et al. PLoS One. 2018 May 9;13(5):e0196598.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright